Lab Invest (2000) 80(4):51327
Ozempic is a widely used medication for managing type 2 diabetes and supporting weight loss, but like many drugs, it can cause unwanted side effects
Clinical Trial Results The SURMOUNT clinical trials demonstrated unprecedented weight loss for a non-surgical treatment
Summary Keywords amylin, calcitonin, dual amylin-calcitonin receptor agonist, DACRA, NAFLD, non-alcoholic fatty liver disease, obesity, pramlintide Citation Mathiesen DS, Lund A, Vilsbll T, Knop FK and Bagger JI (2021) Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
Diabetes Care 46(7):13881394 Perreault L (2018) Goals for medical treatment in obesity and prediabetes: improving outcomes for both
Cook points to his own experience